Zoetis Inc. (NYSE: ZTS) is a timely long position with respect to governmental healthcare policy change uncertainty. With an impressive capital appreciation stock record, the company is still poised to the upside, with roughly 47% for upside performance, based on my analysis. As a worst-case scenario, I have estimated a 10% downside risk ($105). Over the past 6-months, the stock is up about 30%, while over the past year, they are up 35%. According to the company's annual 10-K, as "the largest animal healthcare company by revenue", investors could begin looking to Zoetis